Open access
Jul 2026
Three ct-miRNA signature predicts disease outcome in early breast cancer women.
Considering the accessibility and stability of ct-miRNAs, this signature might improve the recurrence risk prediction identifying who, despite the early diagnosis, might need a more intensive screening or secondary prevention strategies.
G. Cosentino, Mara Lecchi, M. Giussani et al.
· Breast Cancer Research · 0 citations